Skip to content

Glaukos

US · GKOS #1500 by market cap Listed 2015
237.31 -0.79 -0.33%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Price chart

Pre-market 237.00 -0.46%
After-hours 237.31 0.00%
247.16103.12237.312026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on GKOS?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Bullish
  • Recent price momentum is +88.8% on average (3-month/1-year).
  • Main-fund capital flow has been a net inflow over the last 45 sessions.
  • Short interest has risen to 7.6% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Bullish
  • Price is above its 20-day average and above its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.
Quant Rating, last 30 days B → B

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2849 U.S. stocks StockVane covers.

Last computed: 2026-11-21 08:27 UTC

Data coverage: 6 of 6 factors. Missing data is not a zero score.

Overall C+
ValuationGrowthProfitMomentumHealthAnalyst
Valuation F

How expensive the stock is versus earnings, sales and its own 5-year history.

Forward P/E 209.6x Better than 1%
Price / Sales 21.1x Better than 6%
Growth A

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) 21.5% Better than 83%
Net income CAGR (3Y) 50.5% Better than 88%
Profitability D+

How much profit the business keeps from each dollar of sales and capital.

Gross margin 55.7% Better than 70%
Operating margin -39.3% Better than 10%
Net margin -37.0% Better than 10%
Return on equity -26.4% Better than 14%
Return on invested capital -23.7% Better than 12%
Momentum A+

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return 28.4% Better than 98%
6-month return 97.4% Better than 99%
12-month return (ex latest month) 77.4% Better than 92%
Distance below 52-week high 7.0% Better than 91%
Financial Health B

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 4.7x Better than 85%
Debt to assets 11.6% Better than 67%
Interest coverage -40.6x Better than 8%
Free cash flow / net income 133.4% Better than 59%
Analyst View C+

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 90.9% Better than 73%
Upside to average target 0.2% Better than 4%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -3.42%
1M +36.83%
3M +28.35%
6M +65.00%
YTD +110.18%
1Y +149.28%
3Y +271.26%
5Y +393.27%

Key statistics

Price & volume

Prev close
238.10
Open
238.87
Day range
233.40 - 244.55
Avg price
237.52
Volume
1.09M
Turnover
258.79M
Amplitude
4.68%
52-week range
93.96 - 255.19

Valuation

P/E
-72.35
P/E (TTM)
-80.44
P/B
19.58
EPS
-3.28
Net profit
-194.17M
Net assets
717.29M

Share structure

Market cap
14.05B
Float cap
13.54B
Shares out
59.20M
Float shares
57.07M

Dividend & listing

Dividend (TTM)
0.00
Listing date
2015-06-25
52-week range 89% of range
93.96 255.19

7.0% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

+25.06M net over the window

Short interest

Shares short
4.48M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Glaukos (GKOS)?

Glaukos last traded at 237.31. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Glaukos's market cap?

About 14.05B.

What is the P/E ratio of Glaukos?

The trailing twelve-month P/E is -80.44. The Valuation tab shows it against the stock's own five-year range.

Does Glaukos pay a dividend?

Glaukos does not currently pay a regular dividend.

Is Glaukos a buy according to analysts?

The consensus of 11 analysts is a Buy rating, with an average 12-month price target of 237.82, which implies 0.2% upside from the current price. This is not investment advice.

What is Glaukos's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Glaukos a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.

Quote time 2026-11-20 20:02:19 · For reference only, not investment advice and not tailored to your situation.

Glaukos discussion 0 comments

Add a comment